Retraction
Protective Effects of Microrna-22 Against Endothelial Cell Injury by Targeting NLRP3 Through Suppression of the Inflammasome Signaling Pathway in a Rat Model of Coronary Heart Disease
Paper Information
Record ID:
33680
Author(s):
Publication Date:
October 09, 2017
Retraction Date:
November 02, 2021
(4.1 years years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Cellular Physiol Biochem Press
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.33594/000000450Additional Notes:
See also: https://pubpeer.com/publications/D7922899CAF4269558DB6338B096DF
Citations (40)
40
Total Citations10
Post-Retraction(25.0%)
30
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
6
Within 1 year
1
After 2+ years
790
Days since retraction (latest)
MiR-130a-3p inhibits endothelial inflammation by regulating the expression of MAPK8 in endothelial cells
Mingming Gu, Kun Liu, Hui Xiong et al. (4 authors)
Heliyon
Open Access
Published: Jan 2024
2 citations
2 citations
790 days after retraction
MiR-130a-3p inhibits endothelial inflammation by regulating the expression of MAPK8 in endothelial cells
Mingming Gu, Kun Liu, Hui Xiong et al. (4 authors)
Research Square (Research Square)
Open Access
Published: Jul 2023
622 days after retraction
NLRP3 inflammasome pathway in atherosclerosis: Focusing on the therapeutic potential of non-coding RNAs
Sulieman Ibraheem Shelash Al-Hawary, Saade Abdalkareem Jasim, Rosario Mireya Romero‐Parra et al. (12 authors)
Pathology - Research and Practice
Published: Apr 2023
9 citations
9 citations
540 days after retraction
An updated review on cell signaling pathways regulated by candidate miRNAs in coronary artery disease
Imdad Khan, Muhammad Siraj
Non-coding RNA Research
Open Access
Published: Mar 2023
5 citations
5 citations
513 days after retraction
NLRP3 inflammasome: The rising star in cardiovascular diseases
Yidan Zheng, Xu Li, Nianguo Dong et al. (4 authors)
Frontiers in Cardiovascular Medicine
Open Access
Published: Sep 2022
71 citations
71 citations
322 days after retraction
NLRP3 inflammasome activation mechanism and its role in autoimmune liver disease
Yanling Guan, Yiyue Gu, Hao Li et al. (9 authors)
Acta Biochimica et Biophysica Sinica
Open Access
Published: Sep 2022
28 citations
28 citations
319 days after retraction
Recent advances in targeted delivery of non-coding RNA-based therapeutics for atherosclerosis
Xiaoxin Li, Hongzhao Qi, Weigang Cui et al. (9 authors)
Molecular Therapy
Open Access
Published: Aug 2022
39 citations
39 citations
273 days after retraction
Expression levels of miR-22, miR-30c, miR-145, and miR-519d and their possible associations with inflammatory markers among patients with coronary artery disease.
Saied Ghorbani, Seyed Hashem Sezavar, Farah Bokharaei-Salim et al. (12 authors)
PubMed
Published: May 2022
3 citations
3 citations
180 days after retraction
Targeting the NLRP3 inflammasome in cardiovascular diseases
Stefano Toldo, Eleonora Mezzaroma, Leo F. Buckley et al. (8 authors)
Pharmacology & Therapeutics
Open Access
Published: Dec 2021
212 citations
212 citations
39 days after retraction
Programmed Cell Death: Complex Regulatory Networks in Cardiovascular Disease
Liuhua Zhou, Jiateng Sun, Lingfeng Gu et al. (9 authors)
Frontiers in Cell and Developmental Biology
Open Access
Published: Nov 2021
23 citations
23 citations
24 days after retraction
Cytokine storm in the pathophysiology of COVID-19: Possible functional disturbances of miRNAs
Mona Aslani, Seyed Shahabeddin Mortazavi‐Jahromi, Abbas Mirshafiey
International Immunopharmacology
Open Access
Published: Sep 2021
28 citations
28 citations
42 days before retraction
MicroRNA-22 Level in Patients with Multiple Sclerosis and Its Relationship with Vitamin D and Vitamin D Receptor Levels
Ahmed Khedr, Olfat Shaker, Amr Hassan et al. (6 authors)
NeuroImmunoModulation
Published: Sep 2021
2 citations
2 citations
46 days before retraction
NLRP3 Inflammasome in Cardiovascular Disease: David's Stone against Goliath?
Șerban Bălănescu, E. Magda Barbu, Camelia Georgescu et al. (4 authors)
Romanian Journal of Cardiology
Open Access
Published: Sep 2021
4 citations
4 citations
62 days before retraction
Constitutive activation of the NEAT1/miR-22-3p/Ltb4r1 signaling pathway in mice with myocardial injury following acute myocardial infarction
Lijie Wang, Lu Wang, Qi Wang
Aging
Open Access
Published: Jun 2021
13 citations
13 citations
152 days before retraction
MicroRNA-22 in female malignancies: Focusing on breast, cervical, and ovarian cancers
Kazem Nejati‐Koshki, Mohammad Reza Alivand, AmirAhmad Arabzadeh
Pathology - Research and Practice
Published: May 2021
29 citations
29 citations
184 days before retraction
CircMAPK1 promotes the proliferation and migration of vascular smooth muscle cells through miR-22-3p/ methyl-CpG binding protein 2 axis
Xi Fu, Tiesheng Niu, Tiangui Yang et al. (4 authors)
Nutrition Metabolism and Cardiovascular Diseases
Published: Apr 2021
17 citations
17 citations
195 days before retraction
Assessing the Association of Mitochondrial Function and Inflammasome Activation in Murine Macrophages Exposed to Select Mitotoxic Tri-Organotin Compounds
Gabrielle Childers, Caroline Perry, Barbara Blachut et al. (9 authors)
Environmental Health Perspectives
Open Access
Published: Apr 2021
12 citations
12 citations
215 days before retraction
Differences between common endothelial cell models (primary human aortic endothelial cells and EA.hy926 cells) revealed through transcriptomics, bioinformatics, and functional analysis
Dongdong Wang, Zhu Chen, Andy Wai Kan Yeung et al. (4 authors)
Current Research in Biotechnology
Open Access
Published: Jan 2021
11 citations
11 citations
305 days before retraction
Modulatory mechanisms of NLRP3: Potential roles in inflammasome activation
Qihui Ge, Xinnong Chen, Yixuan Zhao et al. (5 authors)
Life Sciences
Published: Dec 2020
21 citations
21 citations
318 days before retraction
The Role of microRNAs in the Development of Type 2 Diabetes Complications
Stavroula Α. Paschou, Gerasimos Siasos, Niki Katsiki et al. (5 authors)
Current Pharmaceutical Design
Published: Nov 2020
7 citations
7 citations
364 days before retraction
Inhibition of <i>EZH2</i> attenuates coronary heart disease by interacting with <i>microRNA‐22</i> to regulate the <i>TXNIP</i> /nuclear factor‐κB pathway
Yong Liu, Dai Chuanzhong, Yuping Lei et al. (5 authors)
Experimental Physiology
Open Access
Published: Oct 2020
13 citations
13 citations
391 days before retraction
NLRP3 inflammasome in endothelial dysfunction
Baochen Bai, Yanyan Yang, Qi Wang et al. (10 authors)
Cell Death and Disease
Open Access
Published: Sep 2020
372 citations
372 citations
410 days before retraction
Inflammasome activation and regulation: toward a better understanding of complex mechanisms
Danping Zheng, Timur Liwinski, Eran Elinav
Cell Discovery
Open Access
Published: Jun 2020
772 citations
772 citations
512 days before retraction
RETRACTED ARTICLE: Anti-inflammatory effect of up-regulated microRNA-221-3p on coronary heart disease via suppressing NLRP3/ASC/pro-caspase-1 inflammasome pathway activation
Jingfeng Rong, Jijie Xu, Qian Liu et al. (8 authors)
Cell Cycle
Open Access
Published: May 2020
9 citations
9 citations
545 days before retraction
NLRP3 Inflammasome and Its Central Role in the Cardiovascular Diseases
Yeqing Tong, Zhihong Wang, Cai Li et al. (6 authors)
Oxidative Medicine and Cellular Longevity
Open Access
Published: Apr 2020
70 citations
70 citations
566 days before retraction
NLRP3 inflammasome, an immune‐inflammatory target in pathogenesis and treatment of cardiovascular diseases
Yucheng Wang, Xiaoxiao Liu, Hui Shi et al. (7 authors)
Clinical and Translational Medicine
Open Access
Published: Mar 2020
168 citations
168 citations
611 days before retraction
Understanding Inflammatory Responses in the Manifestation of Prothrombotic Phenotypes
Shankar Chanchal, Aastha Mishra, Manvendra K. Singh et al. (4 authors)
Frontiers in Cell and Developmental Biology
Open Access
Published: Feb 2020
41 citations
41 citations
628 days before retraction
Micro RNA sequencing for myocardial infarction screening
Sri Harsha Kanuri, Rolf P. Kreutz
Elsevier eBooks
Published: Nov 2019
1 citation
1 citation
711 days before retraction
Atherosclerosis‐associated endothelial cell apoptosis by miRNA let7‐b‐mediated downregulation of HAS‐2
Lijie Zhu, Qingman Li, Datun Qi et al. (7 authors)
Journal of Cellular Biochemistry
Published: Nov 2019
15 citations
15 citations
716 days before retraction
Tuscany Sangiovese grape juice imparts cardioprotection by regulating gene expression of cardioprotective C-type natriuretic peptide
B. Svezia, Manuela Cabiati, Marco Matteucci et al. (7 authors)
European Journal of Nutrition
Published: Nov 2019
16 citations
16 citations
724 days before retraction
Diagnostic and theranostic microRNAs in the pathogenesis of atherosclerosis
Sara Shoeibi
Acta Physiologica
Published: Jul 2019
38 citations
38 citations
831 days before retraction
Regulatory Mechanisms of the NLRP3 Inflammasome, a Novel Immune-Inflammatory Marker in Cardiovascular Diseases
Na An, Yonghong Gao, Zeyu Si et al. (12 authors)
Frontiers in Immunology
Open Access
Published: Jul 2019
106 citations
106 citations
846 days before retraction
Effect of Furostanol Saponins from Allium Macrostemon Bunge Bulbs on Platelet Aggregation Rate and PI3K/Akt Pathway in the Rat Model of Coronary Heart Disease
Hui Feng, Zhipeng Wang, Changsong Wang et al. (9 authors)
Evidence-based Complementary and Alternative Medicine
Open Access
Published: Jun 2019
21 citations
21 citations
863 days before retraction
MicroRNA Post-transcriptional Regulation of the NLRP3 Inflammasome in Immunopathologies
Gülçin Tezcan, Ekaterina Martynova, Zarema E. Gilazieva et al. (6 authors)
Frontiers in Pharmacology
Open Access
Published: May 2019
72 citations
72 citations
916 days before retraction
Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases
Nina Boxberger, Michael Hecker, Uwe K. Zettl
The Journal of Immunology
Open Access
Published: Apr 2019
64 citations
64 citations
938 days before retraction
Protective effects of microRNA‐22‐3p against retinal pigment epithelial inflammatory damage by targeting NLRP3 inflammasome
Zizhong Hu, Xuehua Lv, Lu Chen et al. (9 authors)
Journal of Cellular Physiology
Published: Mar 2019
45 citations
45 citations
949 days before retraction
Long noncoding RNA MALAT1 promotes high glucose-induced human endothelial cells pyroptosis by affecting NLRP3 expression through competitively binding miR-22
Yaxian Song, Lixia Yang, Ruiwei Guo et al. (6 authors)
Biochemical and Biophysical Research Communications
Published: Dec 2018
109 citations
109 citations
1044 days before retraction
Platelet microRNAs in hypertensive patients with and without cardiovascular disease
Maria Marketou, Joanna Kontaraki, John A. Papadakis et al. (14 authors)
Journal of Human Hypertension
Published: Oct 2018
18 citations
18 citations
1099 days before retraction
MicroRNA expression profile of human advanced coronary atherosclerotic plaques
Mariana S. Parahuleva, Christoph Lipps, Behnoush Parviz et al. (7 authors)
Scientific Reports
Open Access
Published: May 2018
67 citations
67 citations
1268 days before retraction
MicroRNA-495 Ameliorates Cardiac Microvascular Endothelial Cell Injury and Inflammatory Reaction by Suppressing the NLRP3 Inflammasome Signaling Pathway
Tao Zhou, Daokang Xiang, Suining Li et al. (6 authors)
Cellular Physiology and Biochemistry
Open Access
Published: Jan 2018
63 citations
63 citations
1401 days before retraction
Quick Stats
Total Citations:
40
Years Since Retraction:
4.1 years
Open Access:
Yes
Last Checked:
Jul 24, 2025